Home
ATOS
ATOS News

Latest Atossa Therapeutics Inc. (ATOS) News on November 12, 2024

Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

7 hours ago

Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Atossa Therapeutics Appoints Claudia Lopez, DVM, MSc, as Vice President, Clinical Product Development

GlobeNewswire

7 days ago

Atossa Therapeutics Appoints Claudia Lopez, DVM, MSc, as Vice President, Clinical Product Development

Atossa Therapeutics Reports Positive KARISMA-Endoxifen Trial Results:

GlobeNewswire

8 days ago

Atossa Therapeutics Reports Positive KARISMA-Endoxifen Trial Results:

Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen’s Potential to Rapidly Reduce Ki-67 and Tumor Volume in ER+/HER2- Breast Cancer

GlobeNewswire

12 days ago

Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen’s Potential to Rapidly Reduce Ki-67 and Tumor Volume in ER+/HER2- Breast Cancer

Are Medical Stocks Lagging Atossa Genetics (ATOS) This Year?

Zacks

15 days ago

Are Medical Stocks Lagging Atossa Genetics (ATOS) This Year?

Atossa Therapeutics to Participate in Fireside Chat with Karolinska Institute at BIO-EUROPE 2024 to Discuss a Unique Swedish American Collaboration to Prevent Breast Cancer

GlobeNewswire

22 days ago

Atossa Therapeutics to Participate in Fireside Chat with Karolinska Institute at BIO-EUROPE 2024 to Discuss a Unique Swedish American Collaboration to Prevent Breast Cancer

Atossa Therapeutics to Present at the 2024 Maxim Healthcare Virtual Summit

GlobeNewswire

a month ago

Atossa Therapeutics to Present at the 2024 Maxim Healthcare Virtual Summit

Atossa Therapeutics Commemorates Breast Cancer Awareness Month, Highlighting the Need for Innovation Across the Breast Cancer Treatment Continuum

GlobeNewswire

a month ago

Atossa Therapeutics Commemorates Breast Cancer Awareness Month, Highlighting the Need for Innovation Across the Breast Cancer Treatment Continuum

Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?

Zacks

2 months ago

Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?

Atossa Therapeutics Announces Support of Final Rule from FDA Requiring Patient Notification of Breast Density, a Critical Step in Addressing a Known Risk Factor for Breast Cancer

GlobeNewswire

2 months ago

Atossa Therapeutics Announces Support of Final Rule from FDA Requiring Patient Notification of Breast Density, a Critical Step in Addressing a Known Risk Factor for Breast Cancer

Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?

Zacks

2 months ago

Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?

Atossa Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

2 months ago

Atossa Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Are You Looking for a Top Momentum Pick? Why Atossa Genetics Inc. (ATOS) is a Great Choice

Zacks

2 months ago

Are You Looking for a Top Momentum Pick? Why Atossa Genetics Inc. (ATOS) is a Great Choice

Atossa Therapeutics Granted Additional Patent Protection for Endoxifen

GlobeNewswire

2 months ago

Atossa Therapeutics Granted Additional Patent Protection for Endoxifen

Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Combining (Z)-Endoxifen with Abemaciclib for ER+/HER2- Breast Cancer

GlobeNewswire

3 months ago

Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Combining (Z)-Endoxifen with Abemaciclib for ER+/HER2- Breast Cancer

Atossa Therapeutics Announces the Appointment of Michael Parks as Vice President, Investor and Public Relations

GlobeNewswire

3 months ago

Atossa Therapeutics Announces the Appointment of Michael Parks as Vice President, Investor and Public Relations

Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

3 months ago

Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Here's Why We're Not Too Worried About Atossa Therapeutics' (NASDAQ:ATOS) Cash Burn Situation

Simply Wall St.

3 months ago

Here's Why We're Not Too Worried About Atossa Therapeutics' (NASDAQ:ATOS) Cash Burn Situation

Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer

GlobeNewswire

4 months ago

Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer

Are Medical Stocks Lagging Atossa Genetics (ATOS) This Year?

Zacks

4 months ago

Are Medical Stocks Lagging Atossa Genetics (ATOS) This Year?

Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer

GlobeNewswire

4 months ago

Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer

Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer

GlobeNewswire

4 months ago

Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer

Are Medical Stocks Lagging Alvotech (ALVO) This Year?

Zacks

5 months ago

Are Medical Stocks Lagging Alvotech (ALVO) This Year?

Atossa Set to Join Russell 3000® Index Effective June 28, 2024

GlobeNewswire

5 months ago

Atossa Set to Join Russell 3000® Index Effective June 28, 2024

Sidoti Events, LLC's Virtual June Small-Cap Conference

ACCESSWIRE

5 months ago

Sidoti Events, LLC's Virtual June Small-Cap Conference

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

5 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Simply Wall St.

5 months ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Simply Wall St.

5 months ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

Simply Wall St.

5 months ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

5 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Simply Wall St.

5 months ago

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Simply Wall St.

5 months ago

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Seoul resumes loudspeaker propaganda against North

AFP

5 months ago

Seoul resumes loudspeaker propaganda against North

Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?

Zacks

5 months ago

Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?

Atossa to Present at the Sidoti Small-Cap Investor Conference

GlobeNewswire

5 months ago

Atossa to Present at the Sidoti Small-Cap Investor Conference

Atossa Therapeutics Announces Support of Clinical Study Testing New, Artificial Intelligence, Breast Cancer Risk Assessment Model

GlobeNewswire

5 months ago

Atossa Therapeutics Announces Support of Clinical Study Testing New, Artificial Intelligence, Breast Cancer Risk Assessment Model

Atossa Genetics Inc. (ATOS) is a Great Momentum Stock: Should You Buy?

Zacks

6 months ago

Atossa Genetics Inc. (ATOS) is a Great Momentum Stock: Should You Buy?

Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial

GlobeNewswire

6 months ago

Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial

Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

6 months ago

Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines

GlobeNewswire

6 months ago

Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines

ACCESSWIRE

6 months ago

Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen

GlobeNewswire

6 months ago

Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen

Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer

GlobeNewswire

7 months ago

Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer

Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference

GlobeNewswire

7 months ago

Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference

Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen

GlobeNewswire

7 months ago

Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen

Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update

GlobeNewswire

7 months ago

Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update

Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved "Expanded Access" Program for a U.S. Breast Cancer Patient

GlobeNewswire

8 months ago

Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved "Expanded Access" Program for a U.S. Breast Cancer Patient

Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements

GlobeNewswire

8 months ago

Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements

Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors

GlobeNewswire

8 months ago

Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors

Data from Atossa’s Phase 2 EVANGELINE Clinical Trial to be Presented at American Association for Cancer Research (AACR) Annual Meeting

GlobeNewswire

8 months ago

Data from Atossa’s Phase 2 EVANGELINE Clinical Trial to be Presented at American Association for Cancer Research (AACR) Annual Meeting

We Think Atossa Therapeutics (NASDAQ:ATOS) Can Afford To Drive Business Growth

Simply Wall St.

8 months ago

We Think Atossa Therapeutics (NASDAQ:ATOS) Can Afford To Drive Business Growth

Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study

GlobeNewswire

9 months ago

Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study

Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial

GlobeNewswire

9 months ago

Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial

Associated Press Finance

10 months ago

Codorus Valley: Q4 Earnings Snapshot

Codorus Valley Bancorp, Inc. Reports Fourth Quarter 2023 Results and Record Earnings for the Year

GlobeNewswire

10 months ago

Codorus Valley Bancorp, Inc. Reports Fourth Quarter 2023 Results and Record Earnings for the Year

Associated Press Finance

10 months ago

Ohio Valley Banc: Q4 Earnings Snapshot

Business Wire

10 months ago

MtronPTI to Present at the Microcap Conference in Atlantic City

Ohio Valley Banc Corp. Reports 4th Quarter and Fiscal Year Earnings

PR Newswire

10 months ago

Ohio Valley Banc Corp. Reports 4th Quarter and Fiscal Year Earnings

IBN Announces Latest Episode of The Stock2Me Podcast featuring Dr. Alan Baratz, CEO of D-Wave Quantum Inc.

GlobeNewswire

10 months ago

IBN Announces Latest Episode of The Stock2Me Podcast featuring Dr. Alan Baratz, CEO of D-Wave Quantum Inc.

NOVONIX to Host Fourth Quarter 2023 Operations Update

GlobeNewswire

10 months ago

NOVONIX to Host Fourth Quarter 2023 Operations Update

GlobeNewswire

10 months ago

National Bankshares, Inc. Announces Agreement to Acquire Frontier Community Bank

Q3 Earnings Outperformers: Shake Shack (NYSE:SHAK) And The Rest Of The Modern Fast Food Stocks

StockStory

10 months ago

Q3 Earnings Outperformers: Shake Shack (NYSE:SHAK) And The Rest Of The Modern Fast Food Stocks

Newsfile

10 months ago

Heritage Global, Inc. to Present at The Microcap Conference on Wednesday, January 31 and Thursday, February 1, 2024

DISCO Announces C-Suite Elevations For Key Customer and People-Focused Roles

Business Wire

10 months ago

DISCO Announces C-Suite Elevations For Key Customer and People-Focused Roles

Seven Hills Realty Trust Fourth Quarter 2023 Conference Call Scheduled for Wednesday, February 21st

Business Wire

10 months ago

Seven Hills Realty Trust Fourth Quarter 2023 Conference Call Scheduled for Wednesday, February 21st

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

GlobeNewswire

10 months ago

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference

GlobeNewswire

10 months ago

Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference

Atossa Therapeutics, Inc. (NASDAQ:ATOS): Is Breakeven Near?

Simply Wall St.

10 months ago

Atossa Therapeutics, Inc. (NASDAQ:ATOS): Is Breakeven Near?

Q3 Modern Fast Food Earnings: Wingstop (NASDAQ:WING) Earns Top Marks

StockStory

10 months ago

Q3 Modern Fast Food Earnings: Wingstop (NASDAQ:WING) Earns Top Marks

Ohio Valley Banc Corp. (NASDAQ:OVBC) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Simply Wall St.

10 months ago

Ohio Valley Banc Corp. (NASDAQ:OVBC) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Spotting Winners: Noodles (NASDAQ:NDLS) And Modern Fast Food Stocks In Q3

StockStory

10 months ago

Spotting Winners: Noodles (NASDAQ:NDLS) And Modern Fast Food Stocks In Q3

CPSI and PointClickCare Announce Exclusive Referral Partnership for TruBridge RCM Services to Skilled Nursing Facilities

Business Wire

10 months ago

CPSI and PointClickCare Announce Exclusive Referral Partnership for TruBridge RCM Services to Skilled Nursing Facilities

CPSI Announces Divestment of American HealthTech to PointClickCare

Business Wire

10 months ago

CPSI Announces Divestment of American HealthTech to PointClickCare

OVBC ANNOUNCES CASH DIVIDEND

PR Newswire

10 months ago

OVBC ANNOUNCES CASH DIVIDEND

Heritage Global, Inc. to Present at the Sequire Investor Summit in Puerto Rico

GlobeNewswire

10 months ago

Heritage Global, Inc. to Present at the Sequire Investor Summit in Puerto Rico

Insider Sell: President William Drafts Sells 9,710 Shares of M-Tron Industries Inc (MPTI)

GuruFocus.com

10 months ago

Insider Sell: President William Drafts Sells 9,710 Shares of M-Tron Industries Inc (MPTI)

Atossa Therapeutics Issues Letter to Shareholders

GlobeNewswire

10 months ago

Atossa Therapeutics Issues Letter to Shareholders

Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

10 months ago

Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

H&E Equipment Services, Inc. Completes Acquisition of Precision Rentals

Business Wire

10 months ago

H&E Equipment Services, Inc. Completes Acquisition of Precision Rentals

NOVONIX Announces Resignation of Daniel Akerson from Board of Directors

GlobeNewswire

a year ago

NOVONIX Announces Resignation of Daniel Akerson from Board of Directors

SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024

Business Wire

a year ago

SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024

Gevo VP of Government Relations Lindsay Fitzgerald and VP of Finance & Strategy Eric Frey to Participate in a Water Tower Research Fireside Chat on Tuesday, December 19th at 10:00 am ET

GlobeNewswire

a year ago

Gevo VP of Government Relations Lindsay Fitzgerald and VP of Finance & Strategy Eric Frey to Participate in a Water Tower Research Fireside Chat on Tuesday, December 19th at 10:00 am ET

Kodiak Sciences Inc. (KOD) Up 43.6% Since Last Earnings Report: Can It Continue?

Zacks

a year ago

Kodiak Sciences Inc. (KOD) Up 43.6% Since Last Earnings Report: Can It Continue?

We're Interested To See How Merrimack Pharmaceuticals (NASDAQ:MACK) Uses Its Cash Hoard To Grow

Simply Wall St.

a year ago

We're Interested To See How Merrimack Pharmaceuticals (NASDAQ:MACK) Uses Its Cash Hoard To Grow

Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?

Zacks

a year ago

Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?

With 48% stake, First Community Corporation (NASDAQ:FCCO) seems to have captured institutional investors' interest

Simply Wall St.

a year ago

With 48% stake, First Community Corporation (NASDAQ:FCCO) seems to have captured institutional investors' interest

Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director

GlobeNewswire

a year ago

Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director

Heritage Insurance Holdings (NYSE:HRTG) shareholder returns have been fantastic, earning 421% in 1 year

Simply Wall St.

a year ago

Heritage Insurance Holdings (NYSE:HRTG) shareholder returns have been fantastic, earning 421% in 1 year

SHL Telemedicine Introduces SmartHeart® Direct-to-Consumer Membership Plan in the US

Business Wire

a year ago

SHL Telemedicine Introduces SmartHeart® Direct-to-Consumer Membership Plan in the US

Angel Oak Mortgage REIT Inc CFO & Treasurer Brandon Filson Sells 24,371 Shares

GuruFocus.com

a year ago

Angel Oak Mortgage REIT Inc CFO & Treasurer Brandon Filson Sells 24,371 Shares

Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference

GlobeNewswire

a year ago

Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference

Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial

GlobeNewswire

a year ago

Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2023 Earnings Call Transcript

Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update

Astria Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update

Business Wire

a year ago

Astria Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update

Atossa Therapeutics Appoints Financial Executive Jonathan Finn to its Board of Directors

GlobeNewswire

a year ago

Atossa Therapeutics Appoints Financial Executive Jonathan Finn to its Board of Directors

Outset Medical Reports Third Quarter 2023 Financial Results

Business Wire

a year ago

Outset Medical Reports Third Quarter 2023 Financial Results

I-Mab Announces Participation at Jefferies and Piper Conferences in November

PR Newswire

a year ago

I-Mab Announces Participation at Jefferies and Piper Conferences in November

Share on Social Networks: